Presentation: Strategies for Amorphous Solid Dispersion Product Development


Serán’s VP of Technology, Erica Schlesinger, PhD, presents a multifaceted approach to technology selection for enabled formulations. In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design.

KEY LEARNINGS

‍Strategic drug product design supports a flexible TPP that allows for development of a relevant and advanceable dosage form for FIH studies

Considering TPP/Product Design in ASD screening

Considering impact of particle properties (SDD vs HME) in product design & performance

CLICK HERE TO VIEW THE PRESENTATION